Bioequivalence of Two Formulations of Parecoxib in Healthy Volunteers Under Fasting Conditions

PHASE4Not yet recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 1, 2024

Primary Completion Date

November 30, 2024

Study Completion Date

December 30, 2024

Conditions

Post-operative PainBioequivalence Study in Healthy Subjects

Interventions

DRUG

Parecoxib

Pharmacokinetic study under fasting conditions

Trial Locations (1)

Taichung Veterans General Hospital, Taichung

All Listed Sponsors

lead

Yung Shin Pharm. Ind. Co., Ltd.

INDUSTRY

NCT06600282 - Bioequivalence of Two Formulations of Parecoxib in Healthy Volunteers Under Fasting Conditions | Biotech Hunter | Biotech Hunter